Company Profile

Plakdx LLC
Profile last edited on: 10/14/21      CAGE: 83NU8      UEI: JGD7TD5B4XL6

Business Identifier: Platelet aggregation as a tool to enable a rapid, proximate, inexpensive means of assessing platelet function.
Year Founded
2018
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5011 North Summit Ridge Road
Tucson, AZ 85750
   (520) 971-9397
   N/A
   N/A
Location: Single
Congr. District: 02
County: 

Public Profile

Platelets are vital blood cells to maintain vascular integrity and foster tissue repair. However, in a range of disease states, they can become “inappropriately” activated. To reduce this activation-risk anti- thrombotic drugs are routinely prescribed to many patients - a condition that is therapeutically effective may also increase the bleeding risk of the patient as a result of drug-induce platelet dysfunction. In circumstances of acute illness and trauma that mayinvolve bleeding, physicians may need to make rapid decisions re. effectiveness of a patient’s platelets as to coagulation competency; and the need for emergent platelet transfusions. Plakdx is addressing platelet aggregation as a tool to aid in this decision making - a rapid, proximate, inexpensive means of assessing platelet funct

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $225,000
Project Title: The Miceli Aggregometer: a Point-Of-Care Platelet Function Analyzer

Key People / Management

  Marvin J Slepian -- CEO

  John Jackson -- CMO

  Frank Laduca -- COO

  Peter Tseng

Company News

There are no news available.